TheEdgeResearch
Home / Stocks / CTSO

Cytosorbents Corporation (CTSO)

NASDAQ Healthcare Medical - Devices
$0.40 ▲ +3.61%
Market Cap
$25.0M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.39
52-Wk Range
0.35-1.22
CEO
Phillip Chan
Country
US
Currency
USD

Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to remove cytokines from the blood. It serves as a complementary treatment in various critical care scenarios, including sepsis, managing complications during and after heart bypass surgery, and improving the viability of donor organs for transplantation. Beyond CytoSorb, Cytosorbents off…

Open full interactive analysis & DCF →